Violation Tracker Individual Record
Company:
Scios Inc.
Current Parent Company:
Johnson & Johnson
Penalty:
$85,000,000
Year:
2011
Date:
October 5, 2011
Offense Group:
healthcare-related offenses
Primary Offense:
off-label or unapproved promotion of medical products
Violation Description:
Scios Inc., a subsidiary of pharmaceutical giant Johnson & Johnson, pleaded guilty to a misdemeanor violation of the Food, Drug and Cosmetic Act for introducing into interstate commerce its heart failure drug, Natrecor, for a use that was not approved by the Food and Drug Administration, the Justice Department announced. The district court also sentenced Scios, based in Fremont, Calif., to pay an $85 million criminal fine in accordance with the plea agreement between Scios and the United States.
Level of Government:
federal
Action Type:
agency action
Agency:
Food and Drug Administration referral to the Justice Department
Civil or Criminal Case:
criminal
HQ Country of Parent:
USA
HQ State of Parent:
New Jersey
Ownership Structure of Parent:
publicly traded
Major Industry of Parent:
pharmaceuticals
Specific Industry of Parent:
pharmaceuticals
Source of Data:
Source Notes:
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note:
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.
